Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm—2019 executive summary.

Cites (291)

Items 201–290 of 290

1. Alirocumab as Add-On to Atorvastatin Versus Other Lipid Treatment Strategies: ODYSSEY OPTIONS I Randomized Trial
   Harold Edward Bays, Daniel Gaudet, Robert Weiss, Juan Lima Ruiz, Gerald Francis Watts, Ioanna Gouni‐Berthold, Jennifer G. Robinson, Jian M. Zhao, Corinne Hanotin, Stephen Donahue · 2015 · The Journal of Clinical Endocrinology & Metabolism
2. Prevention of type 2 diabetes in subjects with prediabetes and metabolic syndrome treated with phentermine and topiramate extended release
   Garvey, W. Timothy, Ryan, Donna H., Henry, Robert, Bohannon, Nancy J.V., Toplak, Hermann, Schwiers, Michael, Troupin, Barbara, Day, Wesley W. · 2014 · Diabetes Care
3. Randomized Clinical Trial of Quick-Release Bromocriptine Among Patients With Type 2 Diabetes on Overall Safety and Cardiovascular Outcomes
   J. Michael Gaziano, Anthony H. Cincotta, Christopher M. O’Connor, Michael Ezrokhi, Dean Rutty, Zhulin Ma, Richard E. Scranton · 2010 · Diabetes Care
4. Long-acting insulin analogues versus NPH human insulin in type 2 diabetes
   Monami, Matteo, Marchionni, Niccolò, Mannucci, Edoardo · 2008 · Diabetes Research and Clinical Practice
5. The cardiovascular safety of diabetes drugs–insights from the rosiglitazone experience
   Hiatt, William R., Kaul, Sanjay, Smith, Robert J. · 2013 · New England Journal of Medicine
6. A Randomized Trial of Improved Weight Loss With a Prepared Meal Plan in Overweight and Obese Patients
   Jill A. Metz, Judith S. Stern, Penny M. Kris‐Etherton, Molly E. Reusser, Cynthia D Morris, Daniel C. Hatton, Suzanne Oparil, Robert Brian Haynes, Lawrence M. Resnick, FX Pi-Sunyer et al. · 2000 · Archives of Internal Medicine
7. Fibrates effect on cardiovascular risk is greater in patients with high triglyceride levels or atherogenic dyslipidemia profile: a systematic review and meta-analysis
   Bruckert, Eric, Labreuche, Julien, Deplanque, Dominique, Touboul, Pierre-Jean, Amarenco, Pierre · 2011 · Journal of Cardiovascular Pharmacology
8. Glycaemic efficacy of glucagon‐like peptide‐1 receptor agonists and dipeptidyl peptidase‐4 inhibitors as add‐on therapy to metformin in subjects with type 2 diabetes—a review and meta analysis
   Deacon, C. F., Mannucci, E., Ahrén, B. · 2012 · Diabetes, Obesity and Metabolism
9. Identifying Psychosocial Interventions That Improve Both Physical and Mental Health in Patients With Diabetes
   Harkness, Elaine, Macdonald, Wendy, Valderas, Jose, Coventry, Peter, Gask, Linda, Bower, Peter · 2010 · Diabetes Care
10. Continuous low- to moderate-intensity exercise training is as effective as moderate- to high-intensity exercise training at lowering blood HbA1c in obese type 2 diabetes patients
    Hansen, D., Dendale, P., Jonkers, R. A. M., Beelen, M., Manders, R. J. F., Corluy, L., Mullens, A., Berger, J., Meeusen, R., van Loon, L. J. C. · 2009 · Diabetologia
11. The Current State of Niacin in Cardiovascular Disease Prevention
    Lavigne, Paul M., Karas, Richard H. · 2013 · Journal of the American College of Cardiology
12. Adjust to Target in Type 2 Diabetes
    Richard M. Bergenstal, Mary Lynn Johnson, Margaret A. Powers, Alan G Wynne, Aleksandra Vlajnic, Priscilla A. Hollander, Marc Rendell · 2008 · Diabetes Care
13. Low-Intensity Exercise Reduces the Prevalence of Hyperglycemia in Type 2 Diabetes
    MANDERS, RALPH J. F., VAN DIJK, JAN-WILLEM M., VAN LOON, LUC J. C. · 2010 · Medicine & Science in Sports & Exercise
14. Effect of saxagliptin as add-on therapy in patients with poorly controlled type 2 diabetes on insulin alone or insulin combined with metformin
    Barnett, Anthony H., Charbonnel, Bernard, Donovan, Mark, Fleming, Douglas · 2012 · Current Medical Research and Opinion
15. American Association of Clinical Endocrinologists’ Position Statement on Obesity and Obesity Medicine
    Jeffrey Ian Mechanick, Alan J. Garber, Yehuda Handelsman, William Timothy Garvey, Dennis M. Beir, Nancy J.V. Bohannon, George A. Bray, Michael A. Bush, John Evans, Daniel L. Hurley et al. · 2012 · Endocrine Practice
16. Sequential intensification of metformin treatment in type 2 diabetes with liraglutide followed by randomized addition of basal insulin prompted by A1c targets
    DeVries, J. Hans, Bain, Stephen C., Rodbard, Helena W., Seufert, Jochen, D’Alessio, David, Thomsen, Anne B., Zychma, Marcin, Rosenstock, Julio, on behalf of the Liraglutide-Detemir Study Group · 2012 · Diabetes Care
17. Polysomnographic and Health-related Quality of Life Correlates of Restless Legs Syndrome in the Sleep Heart Health Study
    John Weyl Winkelman, Susan S Redline, Carol M. Baldwin, Helaine E. Resnick, Anne B. Newman, Daniel J. Gottlieb · 2009 · SLEEP
18. Comparison of the pharmacokinetic and pharmacodynamic profiles of insulin degludec and insulin glargine
    Tim Heise, Ulrike Hövelmann, Leszek Nosek, Lidia Hermanski, Susanne Gammelgaard Bøttcher, Hanne L. Haahr · 2015 · Expert Opinion on Drug Metabolism & Toxicology
19. Prevalence of sleep apnea and electrocardiographic disturbances in morbidly obese patients
    Valencia‐Flores, Matilde, Orea, Arturo, Castaño, Violeta A., Resendiz, Montserrat, Rosales, María, Rebollar, Verónica, Santiago, Victoria, Gallegos, José, Campos, Rosa M., González, Jorge et al. · 2000 · Obesity Research
20. Low-Volume Insulin Degludec 200 Units/mL Once Daily Improves Glycemic Control Similarly to Insulin Glargine With a Low Risk of Hypoglycemia in Insulin-Naïve Patients With Type 2 Diabetes
    Gough, Stephen C.L., Bhargava, Anuj, Jain, Rajeev, Mersebach, Henriette, Rasmussen, Søren, Bergenstal, Richard M. · 2013 · Diabetes Care
21. Weight-loss therapy in type 2 diabetes: effects of phentermine and topiramate extended release
    Garvey, W. Timothy, Ryan, Donna H., Bohannon, Nancy J.V., Kushner, Robert F., Rueger, Miriam, Dvorak, Roman V., Troupin, Barbara · 2014 · Diabetes Care
22. Changes in body weight and serum lipid profile in obese patients treated with orlistat in addition to a hypocaloric diet: a systematic review of randomized clinical trials
    Brian Hutton, Dean A. Fergusson · 2004 · American Journal of Clinical Nutrition
23. Pioglitazone and risk of bladder cancer: a meta‐analysis of controlled studies
    Mazen Saleh Ferwana, Belal Firwana, Rim Hasan, Mouaz Husayn Al-Mallah, S. Kim, Víctor M. Montori, Mohammad Hassan Murad · 2013 · Diabetic Medicine
24. Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes.
    Marco Pahor, Bruce M. Psaty, Michael H. Alderman, William B. Applegate, Jeffrey D. Williamson, Curt Daniel Furberg · 2000 · Diabetes Care
25. Behavioral choice treatment promotes continuing weight loss: Preliminary results of a cognitive-behavioral decision-based treatment for obesity.
    Tracy Sbrocco, Randall Nedegaard, Jay M. Stone, Evelyn L. Lewis · 1999 · Journal of Consulting and Clinical Psychology
26. Death during intensive glycemic therapy of diabetes: mechanisms and implications
    Cryer, Philip E. · 2011 · The American Journal of Medicine
27. Introducing a simplified approach to insulin therapy in type 2 diabetes: a comparison of two single‐dose regimens of insulin glulisine plus insulin glargine and oral antidiabetic drugs
    Mark Lankisch, Klaus Ferlinz, Jack L. Leahy, Werner Alfons Scherbaum, Orals Plus Apidra and LANTUS (OPAL) study group · 2008 · Diabetes Obesity and Metabolism
28. Hypoglycemia in Type 2 Diabetes - More Common Than You Think
    Richa Redhu Gehlaut, Godwin Y. Dogbey, Frank Schwartz, Cynthia R. Marling, Jay H. Shubrook · 2015 · Journal of Diabetes Science and Technology
29. Colesevelam lowers glucose and lipid levels in type 2 diabetes: The clinical evidence
    Fonseca, Vivian A., Handelsman, Yehuda, Staels, Bart · 2010 · Diabetes, Obesity and Metabolism
30. Intensive and Standard Blood Pressure Targets in Patients With Type 2 Diabetes Mellitus: Systematic Review and Meta-analysis
    McBrien, Kerry, Rabi, Doreen M., Campbell, Norm, Barnieh, Lianne, Clement, Fiona, Hemmelgarn, Brenda R., Tonelli, Marcello, Leiter, Lawrence A., Klarenbach, Scott W., Manns, Braden J. · 2012 · Archives of Internal Medicine
31. American Association Of Clinical Endocrinologists And American College Of Endocrinology 2016 Outpatient Glucose Monitoring Consensus Statement
    Timothy Silleck Bailey, George Grunberger, Bruce W. Bode, Yehuda Handelsman, Irl B. Hirsch, Lois Jovanovič, Victor Lawrence Roberts, David Rodbard, William V. Tamborlane, John S.A. Walsh · 2016 · Endocrine Practice
32. Inadequate Sleep as a Contributor to Obesity and Type 2 Diabetes
    Jessica McNeil, Éric Doucet, Jean‐Philippe Chaput · 2013 · Canadian Journal of Diabetes
33. Suppressive effect of EPA on the incidence of coronary events in hypercholesterolemia with impaired glucose metabolism: Sub-analysis of the Japan EPA Lipid Intervention Study (JELIS)
    Oikawa, Shinichi, Yokoyama, Mitsuhiro, Origasa, Hideki, Matsuzaki, Masunori, Matsuzawa, Yuji, Saito, Yasushi, Ishikawa, Yuichi, Sasaki, Jun, Hishida, Hitoshi, Itakura, Hiroshige et al. · 2009 · Atherosclerosis
34. Pioglitazone and Risk for Bone Fracture: Safety Data from a Randomized Clinical Trial
    Viscoli, Catherine M., Inzucchi, Silvio E., Young, Lawrence H., Insogna, Karl L., Conwit, Robin, Furie, Karen L., Gorman, Mark, Kelly, Michael A., Lovejoy, Anne M., Kernan, Walter N. et al. · 2016 · The Journal of Clinical Endocrinology & Metabolism
35. Benefits of Liraglutide Treatment in Overweight and Obese Older Individuals With Prediabetes
    Sun H. Kim, Fahim Abbasi, Cindy A. Lamendola, Alice Liu, Danit Ariel, Patricia Schaaf, Kaylene Grove, Vanessa Tomasso, Hector Ochoa, Yeheng V. Liu et al. · 2013 · Diabetes Care
36. Medical Therapy for the Patient With Obesity
    George A. Bray, Donna H. Ryan · 2012 · Circulation
37. Relationship Between Vitamin B 12 and Sensory and Motor Peripheral Nerve Function in Older Adults
    Kira Leishear, Robert M. Boudreau, Stephanie A. Studenski, Luigi Ferrucci, Caterina Rosano, Nathalie de Rekeneire, Denise K. Houston, Stephen B. Kritchevsky, Ann V. Schwartz, Aaron I. Vinik et al. · 2012 · Journal of the American Geriatrics Society
38. Insulin degludec: L ower day‐to‐day and within‐day variability in pharmacodynamic response compared with insulin glargine 300 U / mL in type 1 diabetes
    Tim Heise, Marianne S. Nørskov, Leszek Nosek, Kadriye Kaplan, Susanne Famulla, Hanne L. Haahr · 2017 · Diabetes Obesity and Metabolism
39. Differential response of cholesterol and particle measures of atherogenic lipoproteins to LDL-lowering therapy: implications for clinical practice
    Allan D. Sniderman · 2008 · Journal of clinical lipidology
40. Acute coronary syndromes and diabetes: is intensive lipid lowering beneficial? Results of the PROVE IT-TIMI 22 trial
    Ahmed, S. · 2006 · European Heart Journal
41. Behavioral choice treatment promotes continuing weight loss: Preliminary results of a cognitive–behavioral decision-based treatment for obesity.
    Tracy Sbrocco, Randall Nedegaard, Jay M. Stone · 1999 · Journal of Consulting and Clinical Psychology
42. Clinical results of treating type 2 diabetic patients with sitagliptin, vildagliptin or saxagliptin – diabetes control and potential adverse events
    Bo Åhrén · 2009 · Best Practice & Research Clinical Endocrinology & Metabolism
43. Association of B12 deficiency and clinical neuropathy with metformin use in type 2 diabetes patients
    AK Singh, Abhishek Kumar, D Karmakar, RK Jha · 2013 · Journal of Postgraduate Medicine
44. Clinical Practice Guidelines for Healthy Eating for the Prevention and Treatment of Metabolic and Endocrine Diseases in Adults: Cosponsored by the American Association of Clinical Endocrinologists/The American College of Endocrinology and the Obesity Society
    J. Michael González-Campoy, KRISTIN N. CASTORINO, Ayesha Ebrahim, Dan Hurley, Lois Jovanovič, Jeffrey Ian Mechanick, Steven M. Petak, Yi‐Hao Yu, Sachiko T. St. Jeor, Kristina Arline Harris et al. · 2013 · Endocrine Practice
45. Cardiovascular and Overall Mortality Risk in Relation to Alcohol Consumption in Patients With Cardiovascular Disease
    Simona Costanzo, Augusto Filippo Di Castelnuovo, Maria Benedetta Donati, Licia Iacoviello, Giovanni de Gaetano · 2010 · Circulation
46. Clinical Practice Guidelines for Healthy Eating for the Prevention and Treatment of Metabolic and Endocrine Diseases in Adults: Cosponsored by the American Association of Clinical Endocrinologists/The American College of Endocrinology and the Obesity Society Executive Summary
    J. Michael González-Campoy, Sachiko T. St. Jeor, KRISTIN N. CASTORINO, Ayesha Ebrahim, Dan Hurley, Lois Jovanovič, Jeffrey Ian Mechanick, Steven M. Petak, Yi‐Hao Yu, Kristina Arline Harris et al. · 2013 · Endocrine Practice
47. Effects of initiation and titration of a single pre‐prandial dose of insulin glulisine while continuing titrated insulin glargine in type 2 diabetes: a 6‐month ‘proof‐of‐concept' study
    D. R. Owens, Stephen D. Luzio, Caroline Sert-Langeron, Matthew C. Riddle · 2011 · Diabetes Obesity and Metabolism
48. Meta‐analysis of individual patient data to assess the risk of hypoglycaemia in people with type 2 diabetes using NPH insulin or insulin glargine
    Philip Home, Andreas Fritsche, S. Schinzel, Massimo Massi‐Benedetti · 2010 · Diabetes Obesity and Metabolism
49. Effect of Bromocriptine‐QR (a Quick‐Release Formulation of Bromocriptine Mesylate) on Major Adverse Cardiovascular Events in Type 2 Diabetes Subjects
    J. Michael Gaziano, Anthony H. Cincotta, Aaron I. Vinik, Lawrence Blonde, Nancy J.V. Bohannon, Richard E. Scranton · 2012 · Journal of the American Heart Association
50. Falls Risk in Older Adults with Type 2 Diabetes
    Aaron I. Vinik, Etta Johanna Vinik, Sheri R. Colberg, Steven Morrison · 2014 · Clinics in Geriatric Medicine
51. Association of sulphonylurea treatment with all-cause and cardiovascular mortality: A systematic review and meta-analysis of observational studies
    Thomas M. Forst, M Hanefeld, Stephan Jacob, Guido Moeser, Gero Schwenk, Andreas Pfützner, Axel Haupt · 2013 · Diabetes and Vascular Disease Research
52. Early Benefit from Structured Care with Atorvastatin in Patients with Coronary Heart Disease and Diabetes Mellitus: A Subgroup Analysis of the GREek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study
    Athyros, Vasilios G., Papageorgiou, Athanasios A., Symeonidis, Athanasios N., Didangelos, Triandafillos P., Pehlivanidis, Anthimos N., Bouloukos, Vasilios I., Mikhailidis, Dimitrios P. · 2003 · Angiology
53. Influence of acute exercise on hyperglycemia in insulin-treated type 2 diabetes
    PRAET, STEPHAN F., MANDERS, RALPH J., LIEVERSE, A. G., KUIPERS, Harm, STEHOUWER, COEN D., KEIZER, HANS A., VAN LOON, LUC J. · 2006 · Medicine & Science in Sports & Exercise
54. New Tools for Weight-Loss Therapy Enable a More Robust Medical Model for Obesity Treatment: Rationale for a Complications-Centric Approach
    William Timothy Garvey · 2013 · Endocrine Practice
55. Human Insulin for Type 2 Diabetes
    Kasia J. Lipska, Irl B. Hirsch, Matthew C. Riddle · 2017 · JAMA
56. Ezetimibe improves postprandial hyperlipidaemia in patients with type IIb hyperlipidaemia
    Daisaku Masuda, Yumiko Nakagawa-Toyama, Kazuhiro Nakatani, M. Inagaki, Kazumi Tsubakio‐Yamamoto, José C. Sandoval, T. Ohama, M. Nishida, Masato Ishigami, Shizuya Yamashita · 2009 · European Journal of Clinical Investigation
57. Role of Bile Acid Sequestrants in the Treatment of Type 2 Diabetes
    Yehuda Handelsman · 2011 · Diabetes Care
58. The treatment of type 2 diabetes in the presence of renal impairment: what we should know about newer therapies
    Melanie Jane Davies, Sudesna Chatterjee, Kamlesh Khunti · 2016 · Clinical Pharmacology Advances and Applications
59. Determining Triglyceride Reductions Needed for Clinical Impact in Severe Hypertriglyceridemia
    Jennifer Briley Christian, Bhakti V. Arondekar, Erin K. Buysman, Terry A. Jacobson, Rose Snipes, Ralph I. Horwitz · 2013 · The American Journal of Medicine
60. The Approach to the Management of the Patient with Neuropathic Pain
    Aaron I. Vinik · 2010 · The Journal of Clinical Endocrinology & Metabolism
61. Niacin treatment of the atherogenic lipid profile and Lp(a) in diabetes
    Jian-Qiu Pan, M. Lin, R. Kesala, J. Van, M. Charles · 2002 · Diabetes, obesity and metabolism
62. Cardiovascular risk in patients achieving low-density lipoprotein cholesterol and particle targets
    Peter Paul Toth, Michael Grabner, Rajeshwari S. Punekar, Ralph A. Quimbo, Mark J. Cziraky, Terry A. Jacobson · 2014 · Atherosclerosis
63. Common Standards of Basal Insulin Titration in T2DM
    Sabine Arnolds, Tim Heise, Frank Flacke, Jochen Sieber · 2013 · Journal of Diabetes Science and Technology
64. Pioglitazone and Risk of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Meta-analysis of Randomized Trials
    Lincoff, A. Michael, Wolski, Kathy, Nicholls, Stephen J., Nissen, Steven E. · 2007 · JAMA
65. An evaluation of a television-delivered behavioral weight loss program: Are the ratings acceptable?
    Andrew W. Meyers, Teresa J. Graves, James Whelan, Deborah R. Barclay · 1996 · Journal of Consulting and Clinical Psychology
66. Exercise Training Improves Glycemic Control in Long-Standing Insulin-Treated Type 2 Diabetic Patients
    De Feyter, Henk M., Praet, Stephan F., van den Broek, Nicole M., Kuipers, Harm, Stehouwer, Coen D., Nicolay, Klaas, Prompers, Jeanine J., van Loon, Luc J.C. · 2007 · Diabetes Care
67. Facilitation of β-cell KATPchannel sulfonylurea sensitivity by a cAMP analog selective for the cAMP-regulated guanine nucleotide exchange factor Epac
    Colin A. Leech, Igor Dzhura, Oleg G. Chepurny, Frank Schwede, Hans‐Gottfried Genieser, George G. Holz · 2010 · Islets
68. Continuous Glucose Monitoring with Multiple Daily Insulin Treatment: Outcome Studies
    Janet B. McGill, Andrew Ahmann · 2017 · Diabetes Technology & Therapeutics
69. One-year sustained glycemic control and weight reduction in type 2 diabetes after addition of liraglutide to metformin followed by insulin detemir according to HbA1c target
    Julio Rosenstock, Helena W. Rodbard, Stephen Charles Bain, David A. D’Alessio, Jochen Seufert, Anne Bloch Thomsen, Claus Bo Svendsen, J. Hans DeVries · 2013 · Journal of Diabetes and its Complications
70. Lipid management: Current diet and drug treatment options
    Neil J. Stone · 1996 · The American Journal of Medicine
71. Prevention of Diabetes Through Lifestyle Intervention: Lessons Learned from the Diabetes Prevention Program and Outcomes Study and its Translation to Practice
    Mary A. Hoskin, George A. Bray, Kathy Hattaway, Prajakta Khare-Ranade, Jeremy J. Pomeroy, Linda Semler, Valarie Weinzierl, Judith Wylie‐Rosett · 2014 · Current Nutrition Reports
72. Insulin Therapy in Type 2 Diabetes Mellitus
    Jack L. Leahy · 2012 · Endocrinology and Metabolism Clinics of North America
73. An evaluation of a television-delivered behavioral weight loss program: Are the ratings acceptable?
    Andrew W. Meyers, Teresa J. Graves, James Whelan · 1996 · Journal of Consulting and Clinical Psychology
74. Hypoglycemia: Minimizing its impact in type 2 diabetes
    Moghissi, Etie, Ismail-Beigi, Faramarz, Devine, Robin Cammarota · 2013 · Endocrine Practice
75. PCSK9 inhibitors: Novel therapeutic agents for the treatment of hypercholesterolemia
    Rutger Verbeek, Robert M. Stoekenbroek, G. Kees Hovingh · 2015 · European Journal of Pharmacology
76. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia
    Aseem Basha M · 2019 · Journal of the Practice of Cardiovascular Sciences
77. Colesevelam HCl effects on atherogenic lipoprotein subclasses in subjects with type 2 diabetes
    Robert S. Rosenson, Stacey L. Abby, Michael R. Jones · 2008 · Atherosclerosis
78. Effects of Different Modes of Exercise Training on Glucose Control and Risk Factors for Complications in Type 2 Diabetic Patients: a Meta-Analysis
    Stefano Balducci, Elena Alessi, Patrizia Cardelli, Stefano Cavallo, Francesco Fallucca, Giuseppe Pugliese · 2007 · Diabetes Care
79. An exploratory trial of basal and prandial insulin initiation and titration for type 2 diabetes in primary care with adjunct retrospective continuous glucose monitoring: INITIATION study
    Irene Blackberry, John Furler, Louise Ginnivan, Jo-Anne Elizabeth Manski-Nankervis, Alicia Josephine Jenkins, Neale D. Cohen, James Donovan Best, Doris Yee Ling Young, Danny Liew, Glenn M. Ward et al. · 2014 · Diabetes Research and Clinical Practice
80. Efficacy of colesevelam on lowering glycemia and lipids
    Aggarwal, Saurabh, Loomba, Rohit S., Arora, Rohit R. · 2012 · Journal of Cardiovascular Pharmacology
81. Patient reported outcomes in adults with type 2 diabetes on basal insulin randomized to addition of mealtime pramlintide or rapid-acting insulin analogs
    Peyrot, Mark, Rubin, Richard R., Polonsky, William H., Jennie Best, H. · 2010 · Current Medical Research and Opinion
82. Effects of a personalized system of skill acquisition and an educational program in the treatment of obesity
    Pamela R. Fuller, Michael G. Perri, Elizabeth A. Leermakers, Laura K. Guyer · 1998 · Addictive Behaviors
83. SGLT2 inhibitors and diabetic ketoacidosis — a growing concern
    Guillermo E. Umpierrez · 2017 · Nature Reviews Endocrinology
84. Meal Replacements for Weight Loss in Type 2 Diabetes in a Community Setting
    Jennifer Beatrice Keogh, Peter Marshall Clifton · 2012 · Journal of Nutrition and Metabolism
85. Cost effectiveness of insulin glargine plus oral antidiabetes drugs compared with premixed insulin alone in patients with type 2 diabetes mellitus in Canada
    Tunis, Sandra L., Sauriol, Luc, Minshall, Michael E. · 2010 · Applied Health Economics and Health Policy
86. Proceedings from the American Association of Clinical Endocrinologists and American College of Endocrinology Consensus Conference on Glucose Monitoring
    George Grunberger, Timothy Silleck Bailey, Pauline M. Camacho, DANIEL F. EINHORN, Alan J. Garber, Yehuda Handelsman, Richard Mack Harrell, Howard M. Lando, Bill Law, Jonathan D. Leffert et al. · 2015 · Endocrine Practice
87. Making Insulin Accessible: Does Inhaled Insulin Fill an Unmet Need?
    Janet B. McGill, David T. Ahn, Steven V. Edelman, C. Rachel Kilpatrick, Tricia Santos Cavaiola · 2016 · Advances in Therapy
88. Sodium glucose transporter 2 inhibition: A new approach to diabetes treatment (抑制钠葡萄糖转运体2：一种新的糖尿病治疗方法)
    Bloomgarden, Zachary · 2013 · Journal of Diabetes
89. Erratum
    2011 · Diabetes Care
90. Comment on: Association of B12 deficiency and clinical neuropathy with metformin use in type 2 diabetes patients
    Mukta N. Chowta, Gaurav Tiwary · 2014 · Journal of Postgraduate Medicine